Experts ensure that early detection and proper prevention are key to tackling the future challenges of cancer

Reasearch, , , , ,

MEDSIR, a leading company dedicated to advancing independent clinical research in oncology on an international level and part of Oncoclínicas & Co, the largest oncology treatment group in Latin America with significant strength in the clinical and outpatient setting, showcased its groundbreaking research at this year’s European Society for Medical Oncology (ESMO) Congress held in Barcelona. The company presented 12 new studies that address various types of cancer, marking a significant scientific milestone for MEDSIR. Continue reading

Related posts:

  1. Experts ensure that early detection and proper prevention are key to tackling the future challenges of cancer
  2. ANEW MEDICAL Receives Notification of Issuance of Alzheimer’s Gene Therapy Patent and Claims by the European Patent Organization (EPO)
  3. FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
  4. Johnson & Johnson is transforming solid tumor cancer outcomes with new data at the 2024 World Conference on Lung Cancer and European Society for Medical Oncology Congress